Category: Contraceptives

Meet our new CEO

Good news for Vasalgel! Ed Gillis has joined the team as CEO of Revolution Contraceptives, LLC, the social venture company that is developing Vasalgel under

Read More »

Two steps forward…

Recent test batch challenges scientists We’ve been happy to share our progress with you — and so much has been accomplished this year! But we

Read More »

Update on RISUG

A much-anticipated update on the development of RISUG (reversible inhibition of sperm under guidance) was provided by journalist Sohini Chattopadhyay in a recent article in The Wire.

Read More »
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today